POH 0.00% 0.0¢ progress 2023-2 trust

Ann: Phosphagenics Arbitration Award Issued, page-178

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,498 Posts.
    lightbulb Created with Sketch. 310
    PM

    Could have something to do with this approval this year for Mylan Dapto and being placed under their label as per a prev recent POH Ann. 

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205037

    I am assuming if our agreement has strict requirements re a generic Dapto being approved and sold then it could imply that mylan have not adhered to developing a TPM Dapto as per agreement opting to produce generic first against terms of agreement. 

    Hence why POH indicate they have to weigh up their options on that as a breach maybe. 
 
watchlist Created with Sketch. Add POH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.